Roche Holding AG Hematology Update Transcript - Thomson StreetEvents

Roche Holding AG Hematology Update Transcript

Roche Holding AG Hematology Update Transcript - Thomson StreetEvents
Roche Holding AG Hematology Update Transcript
Published Jun 23, 2025
14 pages (9781 words) — Published Jun 23, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ROG.S conference call or presentation 23-Jun-25 5:00pm GMT

  
Brief Excerpt:

...Operator Well ladies and gentlemen, welcome to Roche Virtual Hematology Investor event. My name is Henrik, and I'm the technical operator for today's call. Kindly note that the webinar is being recorded. (Operator Instructions) One last remark, if you want to follow the presented slides on your end as well, please feel free to go to roche.com/investors to download the presentation. At this time, it's my pleasure to introduce you to Bruno Eschli, Head of Investor Relations. Bruno, the stage is yours. Bruno Eschli ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Roche Holding AG
Ticker
ROG.S
Time
5:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Colin White - UBS - Analyst : Hi, thanks for taking my question. I just wanted to ask a pretty basic one about -- obviously, we saw some competitor data in the hemophilia A as well at the conference. And I just wanted -- if you could talk a little bit about how you see the market -- the hemophilia A market playing out with that competitor reaching the market, the options that you're giving with Hemlibra, the new things that you're offering with Hemlibra. So how you see it playing out? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JUNE 23, 2025 / 5:00PM, ROG.S - Roche Holding AG Hematology Update And then when we could expect NXT007 to reach the market, and what you would expect to happen at that point? And then I guess a part of this question as well is if you -- that's on the Factor [V3] side. But then if you could explain a little bit about how you see the gene therapies -- your new gene therapy coming in and fitting into treatment, that would be helpful as well. Thanks very much.

Question: Colin White - UBS - Analyst : Yes, thank you very much. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JUNE 23, 2025 / 5:00PM, ROG.S - Roche Holding AG Hematology Update

Table Of Contents

Roche Holding AG Virtual Oncology/SABCS Investor Event Transcript – 2025-12-11 – US$ 54.00 – Edited Transcript of ROG.S corporate analyst meeting</ 11-Dec-25 3:30pm GMT

Q3 2025 Roche Holding AG Corporate Sales Call Transcript – 2025-10-23 – US$ 54.00 – Edited Transcript of ROG.S sales update conference call or presentation 23-Oct-25 12:00pm GMT

Roche Holding AG Pharma Day Transcript – 2025-09-22 – US$ 54.00 – Edited Transcript of ROG.S corporate analyst meeting</ 22-Sep-25 7:00am GMT

Half Year 2025 Roche Holding AG Earnings Call Transcript – 2025-07-24 – US$ 54.00 – Edited Transcript of ROG.S earnings conference call or presentation 24-Jul-25 12:00pm GMT

Roche Holding AG Diagnostics Day Transcript – 2025-05-27 – US$ 54.00 – Edited Transcript of ROG.S corporate analyst meeting</ 27-May-25 12:00pm GMT

Q1 2025 Roche Holding AG Corporate Sales Call Transcript – 2025-04-24 – US$ 54.00 – Edited Transcript of ROG.S sales update conference call or presentation 24-Apr-25 12:00pm GMT

Roche Holding AG Neurology Update Virtual Event Transcript – 2025-04-04 – US$ 54.00 – Edited Transcript of ROG.S conference call or presentation 4-Apr-25 2:00pm GMT

Roche Holding AG Update on Sequencing Technology Presentation Transcript – 2025-02-20 – US$ 54.00 – Edited Transcript of ROG.S conference call or presentation 20-Feb-25 7:30pm GMT

Roche Holding AG Virtual Immunology/WCN Investor Event Transcript – 2025-02-07 – US$ 54.00 – Edited Transcript of ROG.S conference call or presentation 7-Feb-25 3:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Roche Holding AG Hematology Update Transcript" Jun 23, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Roche-Holding-AG-Hematology-Update-T16339940>
  
APA:
Thomson StreetEvents. (2025). Roche Holding AG Hematology Update Transcript Jun 23, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Roche-Holding-AG-Hematology-Update-T16339940>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.